NCT00059267View on ClinicalTrials.gov

Prevention of Recurrent Hepatitis B After Liver Transplantation

CompletedOBSERVATIONAL
Enrollment

317

Participants

Timeline

Start Date

March 31, 2001

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Hepatitis BCirrhosisAcute Liver FailureHepatocellular Carcinoma
Interventions
DRUG

HBIG, Epivir, Hepsera

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

University of Michigan

OTHER

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00059267 - Prevention of Recurrent Hepatitis B After Liver Transplantation | Biotech Hunter | Biotech Hunter